Report Highlights
The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.
Report Includes
- 17 data tables and 105 additional tables
- An overview of the global market landscape related to the 3D cell cultures technologies
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to 3D cell cultures technologies, accompanied by a comprehensive market share analysis categorized by type, end user, and geographical region
- Information on analytical systems used in tissue and cell culture, cellomics, and human cancer model initiative (HCMI)
- Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
- A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
- Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
- Relevant patent analysis, including recent activity and a list of key patents
- Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses, including Abcam PLC, Agilent Technologies Inc., Corning Inc., Merck KGAA, Beckman Coulter, and Synvivo Inc.
Report Scope
This report aims to provide a comprehensive study of the global 3D cell culture technologies market. It provides a detailed description of the different types of healthcare interoperability solutions and their current and historical market revenues.
The scope of the report encompasses the major types of 3D cell culture which are being used by industry, academic researchers, government labs, and independent research groups. This includes the main inputs such as cell lines, media, sera, reagents, software, and instrumentation. It analyzes the current market status, examines future market drivers and presents forecasts of growth over the next five years.
The market structure has been reorganized for this edition. Also, more research was done on base case data for different product areas. The greater emphasis is on the different products used for 3D cell culture, but the report also investigates the market in terms of types of applications, end users and geographic regions.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||||||||||||||||||
| Base year market size | $2.5 billion | ||||||||||||||||||||||||||||||||
| Market size forecast | $14.8 billion | ||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 26.5% for the forecast period of 2023-2028 | ||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||
| Segments covered | Type, Application, End-User, and Geographic Region | ||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||||||||||||||||||||||
| Countries covered | U.S, Canada, Mexico, France, Germany, Italy, Spain, UK, Russia, China, India, Japan, South Korea, and South Africa | ||||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Government regulations and mandates
- Rising demand for tissue engineering
- Advancements in healthcare technology.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Consulting Editor’s Credentials
Dr. Marianna Tcherpakov has more than 10 years of experience as a bench scientist specializing in the areas of biochemistry, cell biology, assay development, antibody and drug manufacturing. She has authored several scientific publications in peer review journals. In the last 10 years, Marianna worked as a business development professional in CRO/CDMO industry. She is familiar with pharmaceutical and biotech landscape, trends and potential future developments in industry.
Report Highlights
The global market for cell culture should grow from $10.3 billion in 2020 to $14.8 billion by 2025, at a compound annual growth rate (CAGR) of 7.5% for the period of 2020-2025.
Report Includes
- 79 tables
- An overview of the global markets and technologies for 3D cell cultures
- Estimation of the market size and analyses of global market trends with estimated data from 2020 to 2024, and projections of compound annual growth rates (CAGRs) through 2025
- Information on analytical systems used in tissue and cell culture, cellomics and human cancer model initiative (HCMI)
- Details about assay development for mesenchymal stem cells, In Vitro testing of adventitious agents and description of assays and assay kits
- A look at the main classes of models for researching cancer and other diseases, benefits of 3D models to cancer research and description of 3D engineered scaffolds
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities and discussion on the impact of COVID-19 on the world of cell culture
- Insights into U.S. regulatory status of bioprinted products; basic guidance for the regulation of biologics, regenerative medicine and xenotransplants
- Relevant patent analysis, including recent activity and a list of key patents
- Market share analysis of the major players in the industry and their comprehensive company profiles including Agilent Technologies, BioVision Inc., Cell Applications Inc., Envisiontec Inc., Mitra Biotech Inc., Promega Corp. and Thermo Fisher Scientific
Report Highlights
The three-dimensional cell culture market reached $1.0 billion in 2016 and should reach $3.9 billion in 2021, with a compound annual growth rate (CAGR) of 30.7% from 2016 to 2021.
Report Includes
- An overview of the global markets and technologies for 3D cell cultures.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information on 3D technologies, with a focus on representative platforms, including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
- Value-chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or relationship building.
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Relevant patent analysis, including recent activity and a list of key patents.
- Profiles of major players in the industry.
Report Highlights
The three dimensional cell culture market was $438.1 million in 2013. This market is expected to grow to $586.1 million in 2014 and about $2.2 billion in 2019, with a compound annual growth rate (CAGR) of 30.1%.
Report Includes
- An overview of the global markets and technologies for 3D cell cultures.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compound annual growth rates (CAGRs) through 2019.
- Information on 3D technologies with a focus on representative platforms including cube, spherical droplet, stacked plate, magnetic bead, and other platforms.
- Value chain analysis at the following levels: key innovation or founding intellectual property, prototyping, beta testing, and research collaborations or reltationship building.
- Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
- Relevant patent analysis including recent activity and a list of key patents.
- Comprehensive profiles of major players in the industry.
Related Reports
Laboratory Animal Models, 3D Cultures and Organoids: Global Markets
The global market for organoids is estimated to increase from $1.4 billion in 2022 to reach $3.7 billion by 2027 with a compound annual growth rate (CAGR) of 22.2% from 2022 through 2027.
Current Bioprinting Prospects and Future Innovations
The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Non-Fungible Tokens (NFT): Global Market
The global NFTs market should reach $37.6 billion by 2022 and $125.6 billion by 2027, with a compound annual growth rate (CAGR) of 27.3% during the forecast period of 2022-2027.
AI in Mental Health: Global Market Outlook
The report provides an overview of the global AI in mental health market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. Revenue forecasts for this period are segmented based on organization size, component, provider, type, industry, and geography. It also highlights major trends and challenges that affect the market and the vendor landscape.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More